Similar articles for PMID: 22851620

Year	Number of Results
1989	3
1991	1
1992	1
1994	3
1996	1
1997	1
1999	3
2000	1
2001	1
2002	4
2003	5
2004	1
2005	4
2006	7
2007	4
2008	4
2009	5
2010	9
2011	2
2012	4
2013	3
2014	3
2015	2
2016	5
2017	2
2024	0

1

Aspirin prophylaxis in people without prior cardiovascular disease does not lead to reductions in cardiovascular death or cancer mortality.

Farooq MU, Gorelick PB. Farooq MU, et al. Evid Based Med. 2013 Apr;18(2):e14. doi: 10.1136/eb-2012-100690. Epub 2012 Jul 31. Evid Based Med. 2013. PMID: 22851620 No abstract available.

2

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Berger JS, et al. JAMA. 2009 May 13;301(18):1909-19. doi: 10.1001/jama.2009.623. JAMA. 2009. PMID: 19436018

3

Aspirin in the primary prevention of cardiovascular disease.

Hennekens CH, Buring JE. Hennekens CH, et al. Cardiol Clin. 1994 Aug;12(3):443-50. Cardiol Clin. 1994. PMID: 7805078 Review.

4

Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.

Kunutsor SK, Seidu S, Khunti K. Kunutsor SK, et al. Diabet Med. 2017 Mar;34(3):316-327. doi: 10.1111/dme.13133. Epub 2016 May 22. Diabet Med. 2017. PMID: 27086572 Review.

5

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.

Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, Natarajan K, Sheng-Lin C, Fiedorek FT, Belder R. Hennekens CH, et al. Arch Intern Med. 2004 Jan 12;164(1):40-4. doi: 10.1001/archinte.164.1.40. Arch Intern Med. 2004. PMID: 14718320

6

Aspirin for primary prevention of cardiovascular disease?

[No authors listed] [No authors listed] Drug Ther Bull. 2009 Nov;47(11):122-5. doi: 10.1136/dtb.2009.10.0045. Drug Ther Bull. 2009. PMID: 19887685

7

Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status.

Xie M, Shan Z, Zhang Y, Chen S, Yang W, Bao W, Rong Y, Yu X, Hu FB, Liu L. Xie M, et al. PLoS One. 2014 Oct 31;9(10):e90286. doi: 10.1371/journal.pone.0090286. eCollection 2014. PLoS One. 2014. PMID: 25360605 Free PMC article.

8

Aspirin in the treatment and prevention of cardiovascular disease.

Gaziano JM, Skerrett PJ, Buring JE. Gaziano JM, et al. Haemostasis. 2000;30 Suppl 3:1-13. doi: 10.1159/000054193. Haemostasis. 2000. PMID: 11182624 Review.

9

Aspirin therapy in primary prevention: comment on "effect of aspirin on vascular and nonvascular outcomes".

Mora S. Mora S. Arch Intern Med. 2012 Feb 13;172(3):217-8. doi: 10.1001/archinternmed.2011.626. Epub 2012 Jan 9. Arch Intern Med. 2012. PMID: 22231608 No abstract available.

10

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Berger JS, et al. JAMA. 2006 Jan 18;295(3):306-13. doi: 10.1001/jama.295.3.306. JAMA. 2006. PMID: 16418466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

74 results

Results by year